Innoviva (INVA) Inventory (2012 - 2026)
Innoviva posted quarterly Inventory of $38.8 million for Q1 2026, down 6.36% year-on-year from $41.5 million in Q1 2025, and down 0.84% on a QoQ basis from $39.2 million in Q4 2025.
Innoviva (INVA) has 8 years of Inventory data on file, last reported at $38.8 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory fell 6.36% year-over-year to $38.8 million; the trailing twelve-month figure through Mar 2026 stood at $38.8 million (down 6.36% YoY), and the FY2025 full-year result was $39.2 million, up 16.15% from the prior year.
- Inventory for Q1 2026 stood at $38.8 million, down from $39.2 million in the prior quarter.
- Across five years, Inventory topped out at $70.8 million in Q3 2022 and bottomed at $33.7 million in Q4 2024.
- The 5-year median for Inventory is $40.5 million (2023), against an average of $43.6 million.
- The widest annual swing landed in 2023, when Inventory tumbled 42.78%; it then jumped 33.64% in 2025.
- A 5-year view of Inventory shows it stood at $55.9 million in 2022, then slipped by 27.12% to $40.7 million in 2023, then slipped by 17.21% to $33.7 million in 2024, then advanced by 16.15% to $39.2 million in 2025, then declined by 0.84% to $38.8 million in 2026.
- The last three Inventory figures came in at $38.8 million (Q1 2026), $39.2 million (Q4 2025), and $38.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 38.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.84 Mn |
| Dec 31, 2025 | 39.17 Mn |
| Sep 30, 2025 | 38.36 Mn |
| Jun 30, 2025 | 49.00 Mn |
| Mar 31, 2025 | 41.48 Mn |
| Dec 31, 2024 | 33.73 Mn |
| Sep 30, 2024 | 34.24 Mn |
| Jun 30, 2024 | 36.66 Mn |
| Mar 31, 2024 | 37.44 Mn |
| Dec 31, 2023 | 40.74 Mn |
| Sep 30, 2023 | 40.52 Mn |
| Jun 30, 2023 | 46.85 Mn |
| Mar 31, 2023 | 49.65 Mn |
| Dec 31, 2022 | 55.90 Mn |
| Sep 30, 2022 | 70.81 Mn |
| Mar 31, 2014 | 11.01 Mn |
| Dec 31, 2013 | 10.41 Mn |
| Sep 30, 2013 | 9.04 Mn |
| Jun 30, 2013 | 8.24 Mn |
| Dec 31, 2012 | 7.51 Mn |